Key facts
- Crystal Adam, R&D president at Tango Therapeutics, sold shares.
- The value of the shares sold was $617,000.
Crystal Adam, the President of Research and Development at Tango Therapeutics, has sold shares of the company. The transaction amounted to $617,000. The sale involved shares of Tango Therapeutics.